Insider Transactions in Q3 2024 at Outlook Therapeutics, Inc. (OTLK)
Insider Transaction List (Q3 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 26
2024
|
Lawrence A Kenyon Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+45.68%
|
$25,000
$5.69 P/Share
|